Period | Date | Adjusted Actuals EPS | GAAP EPS |
---|---|---|---|
Q1 2021 | 2021-05-06 | Future report Set alerts | |
Q4 2020 | 2021-02-26 | 0.51 | 0.51 |
Q3 2020 | 2020-11-06 | 0.00 | 0.00 |
Q2 2020 | 2020-08-07 | 0.19 | 0.07 |
Q1 2020 | 2020-05-08 | 0.32 | 0.14 |
Q4 2019 | 2020-02-21 | 0.27 | 0.20 |
Q3 2019 | 2019-11-01 | 0.30 | 0.24 |
Q2 2019 | 2019-08-02 | 0.41 | 0.33 |
Q1 2019 | 2019-05-03 | 0.35 | 0.22 |
Q4 2018 | 2019-02-22 | 0.31 | 0.38 |
2016-06-01 | Initiated Coverage | Credit Suisse | Outperform | $19.00 |
2016-06-01 | Initiated Coverage | Credit Suisse Group AG | Outperform | $19.00 |
2016-05-31 | Reiterated Rating | Wells Fargo | Buy | |
2016-05-31 | Reiterated Rating | Wells Fargo & Co. | Buy | |
2016-05-24 | Reiterated Rating | Jefferies Group | Buy | $19.00 |
2016-05-09 | Reiterated Rating | Jefferies Group | Buy | $14.00 to $19.00 |
2016-04-29 | Upgrade | Oppenheimer | Sector Perform to Outperform | $21.00 |
2016-04-29 | Upgrade | Oppenheimer Holdings Inc. | Sector Perform to Outperform | $21.00 |
2016-04-12 | Initiated Coverage | Avondale Partners | Outperform | $18.00 |
2016-03-24 | Reiterated Rating | Wells Fargo | Buy | |
2015-08-24 | Reiterated Rating | William Blair | Buy | |
2015-08-10 | Reiterated Rating | Jefferies Group | Buy | $21.00 to $14.00 |
2015-08-03 | Downgrade | Oppenheimer | Outperform to Market Perform | |
2015-07-22 | Reiterated Rating | Oppenheimer | Buy | |
2015-07-21 | Downgrade | Bank of America | Buy to Neutral | |
2015-07-21 | Downgrade | Bank of America Corp. | Buy to Neutral | |
2015-07-13 | Reiterated Rating | Oppenheimer | Buy | $20.00 |
2015-06-18 | Reiterated Rating | Stephens | Outperform | $20.00 |
2015-06-17 | Initiated Coverage | Oppenheimer | Outperform | $20.00 |
2015-03-18 | Initiated Coverage | Robert W. Baird | Outperform | $27.00 |
2015-03-09 | Upgrade | Dougherty & Co | Neutral to Buy | $22.00 to $22.00 |
2015-03-02 | Lower Price Target | Oppenheimer | Outperform | $26.00 to $22.00 |
2014-09-05 | Initiated Coverage | Stephens | Overweight | $25.00 |
2014-08-18 | Reiterated Rating | Wells Fargo & Co. | Positive | |
2014-08-18 | Upgrade | First Analysis | Equal Weight to Overweight | $27.00 |
2014-08-18 | Reiterated Rating | Wells Fargo | Positive | |
2014-07-10 | Reiterated | RBC Capital Mkts | Outperform | $20 to $23 |
2014-07-10 | Boost Price Target | Oppenheimer | Outperform | $20.00 to $23.00 |
2014-07-10 | Boost Price Target | RBC Capital | Outperform | $20.00 to $23.00 |
2014-07-10 | Boost Price Target | Royal Bank Of Canada | Outperform | $20.00 to $23.00 |
2014-05-12 | Reiterated Rating | Jefferies Group | Buy | $28.00 to $23.00 |
2014-04-28 | Upgrade | Ned Davis Research | Neutral to Buy | |
2014-04-24 | Upgrade | Oppenheimer | Market Perform to Outperform | $20.00 |
2014-03-03 | Lower Price Target | Jefferies Group | $30.00 to $28.00 | |
2013-04-29 | Reiterated | Dougherty & Company | Buy | $32.50 to $31 |
2013-02-25 | Reiterated | Dougherty & Company | Buy | $28 to $32.50 |
2012-12-20 | Reiterated | Dougherty & Company | Buy | $27 to $28 |
2012-06-28 | Reiterated | Dougherty & Company | Buy | $32 to $37 |
2012-02-21 | Reiterated | Dougherty & Company | Buy | $32 to $40 |
2010-07-07 | Initiated | Dougherty & Company | Buy | $65 |
2010-01-05 | Downgrade | Jefferies & Co | Buy to Hold | $50 to $52 |
2009-07-08 | Reiterated | Jefferies & Co | Buy | $42 to $48 |
2009-02-23 | Downgrade | Jefferies & Co | Buy to Hold | $32.50 to $36 |
2008-07-22 | Initiated | First Analysis Sec | Overweight | $27 |
2008-01-18 | Reiterated | Jefferies & Co | Buy | $37.50 to $41 |
2008-01-04 | Reiterated | Jefferies & Co | Buy | $32 to $37.50 |
2007-11-30 | Initiated | Banc of America Sec | Buy | $40 |
2016-06-01 | Initiated Coverage | Credit Suisse | Outperform | $19.00 |
2016-06-01 | Initiated Coverage | Credit Suisse Group AG | Outperform | $19.00 |
2016-05-31 | Reiterated Rating | Wells Fargo | Buy | |
2016-05-31 | Reiterated Rating | Wells Fargo & Co. | Buy | |
2016-05-24 | Reiterated Rating | Jefferies Group | Buy | $19.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In HMSY 30 funds of 2213 total. Show all
Fund name | Ticker shares |
---|---|
RS INVESTMENT MANAGEMENT CO LLC | 7.59M |
BlackRock Fund Advisors | 6.82M |
BlackRock Institutional Trust Company, N.A. | 2.35M |
CLIFTON PARK CAPITAL MANAGEMENT, LLC | 1.54M |
TEACHERS ADVISORS INC | 0.88M |
RUSSELL FRANK CO/ | 0.55M |
TIAA CREF INVESTMENT MANAGEMENT LLC | 0.46M |
BlackRock Investment Management, LLC | 0.43M |
MANAGED ACCOUNT ADVISORS LLC | 0.42M |
AHL Partners LLP | 0.30M |
BlackRock Group LTD | 0.18M |
EAGLE BOSTON INVESTMENT MANAGEMENT INC | 0.13M |
Century Capital Management, LLC | 0.11M |
Aperio Group, LLC | 47967 |
BLACKROCK ADVISORS LLC | 44663 |
Name Relationship | Total Shares | Holding stocks |
---|---|---|
LUCIA WILLIAM C CEO | 0.27% (235828) | HMSY / |
Sherman Jeffrey Scott EVP, CFO & Treasurer | 0.19% (169264) | HMSY / LPNT / |
Miller III William F | 0.19% (168611) | HMSY / |
Dragonetti Christina Chief Development Officer | 0.19% (162810) | HMSY / |
Hosp Walter D EVP and CFO | 0.17% (147698) | HMSY / |
Williams Douglas M. Division President | 0.15% (130431) | HMSY / |
Wagner Semone EVP, Operations | 0.12% (102567) | HMSY / |
South Teresa SVP, Human Resources | 0.12% (101419) | HMSY / |
STOWE RICHARD H | 0.10% (90055) | HMSY / |
HOLSTER ROBERT M | 0.10% (87000) | HMSY / |
Nustad Cynthia CIO | 0.09% (76008) | HMSY / |
RUDNICK ELLEN A | 0.07% (65082) | FMBI / HMSY / PDCO / |
Bjorck Meredith W EVP, General Counsel & Sec. | 0.07% (59386) | HMSY / |
Schwartz Bart M | 0.07% (59170) | HMSY / KDMN / |
Mosakowski William S | 0.06% (50149) | HMSY / |
TELLEZ CORA M | 0.06% (49911) | CRMD / HMSY / PPBI / |
DEFELICE EUGENE V EVP, General Counsel | 0.06% (49313) | BKS / HMSY / RAX / |
CALLEN CRAIG R | 0.05% (44784) | HMSY / OHI / |
Perrin Maria Chief Marketing Officer | 0.05% (39699) | HMSY / |
Young Spencer President, HealthDataInsights | 0.04% (38409) | HMSY / |
Aunan Greg D SVP, Chief Accounting Officer | 0.04% (35540) | HMSY / |
Benko Andrea Executive Vice President | 0.04% (31330) | HMSY / |
O'Gara Emmet EVP, Total Population Mgmt | 0.03% (23612) | HMSY / |
Becker Robert | 0.03% (22744) | HMSY / |
Portice Joel Division President | 0.03% (22691) | HMSY / |
Azar Alex M II | 0.02% (17034) | HMSY / |
Donabauer Joseph M VP and Controller | 0.01% (13055) | HMSY / |
Singh Ronald D EVP, Managed Care | 0.01% (11821) | HMSY / |
Mendelson Daniel Newman | 0.01% (9552) | CSBR / HMSY / |
Lalani Jzaneen Chief Corporate Counsel | 0.01% (7432) | HMSY / |
Marshall Edith S General Counsel | 0.01% (6054) | HMSY / |